AVITA Medical (AVHHL) Change in Accured Expenses (2019 - 2025)
AVITA Medical's (AVHHL) quarterly Change in Accured Expenses came in at $7.4 million in Q4 2025, up 996.44% on a YoY basis from $675000.0 in Q4 2024, and up 444.87% quarter-over-quarter from -$2.1 million in Q3 2025.
Analysis
AVITA Medical (AVHHL) Change in Accured Expenses (2019 - 2025) Analysis & Trends
AVITA Medical (AVHHL) has reported Change in Accured Expenses for 7 consecutive years, with $7.4 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Change in Accured Expenses rose 996.44% year-over-year to $7.4 million; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (up 10.73% YoY), and the FY2025 full-year result was $2.7 million, up 10.73% from the prior year.
- Change in Accured Expenses improved to $7.4 million in Q4 2025 per AVHHL's latest filing, from -$2.1 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $7.4 million in Q4 2025 and bottomed at -$4.8 million in Q2 2025.
- Historically, Change in Accured Expenses has averaged $321647.1 across 5 years, with a median of $427000.0 in 2023.
- The widest YoY moves for Change in Accured Expenses: up 996.44% in 2025, down 730.21% in 2025.
- Over 5 years, Change in Accured Expenses stood at -$655000.0 in 2021, then soared by 697.56% to $3.9 million in 2022, then tumbled by 72.48% to $1.1 million in 2023, then sank by 37.33% to $675000.0 in 2024, then jumped by 996.44% to $7.4 million in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered $7.4 million, -$2.1 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.69 Bn | 179.09 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 124.81 Bn | 119.59 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 118.82 Bn | 110.00 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 104.59 Bn | 101.11 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 67.22 Bn | 66.69 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 49.87 Bn | 45.62 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 33.98 Bn | 32.52 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 32.23 Bn | 30.28 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 21.21 Bn | 20.72 Bn | 684.20 Mn | 4.80 Mn |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.40 Mn |
| Sep 30, 2025 | -2.15 Mn |
| Jun 30, 2025 | -4.84 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 675,000.00 |
| Sep 30, 2024 | 3.21 Mn |
| Jun 30, 2024 | 768,000.00 |
| Mar 31, 2024 | -2.17 Mn |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 427,000.00 |
| Jun 30, 2023 | 3.70 Mn |
| Mar 31, 2023 | -2.96 Mn |
| Dec 31, 2022 | 3.91 Mn |
| Mar 31, 2022 | -2.45 Mn |
| Sep 30, 2021 | -655,000.00 |
| Jun 30, 2021 | -983,000.00 |
| Mar 31, 2021 | -1.83 Mn |
| Dec 31, 2020 | -840,000.00 |
| Sep 30, 2020 | -860,000.00 |
| Jun 30, 2020 | 1.69 Mn |